ReviewCureus2025
Exploring the Escalating Trends and Variances in Attention Deficit Hyperactivity Disorder Prevalence: A Critical Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this review is to present the prevalence of ADHD (Attention Deficit Hyperactivity Disorder) from both a global perspective and across various subgroups of people, using evidence from the current literature. This review will also explore variation in ADHD prevalence based on various factors such as race and gender. The review aims to provide insights into potential mechanisms that explain the synthesised data. We conducted a comprehensive electronic literature search on PubMed, Web of Science, and Google Scholar using search terms such as "ADHD prevalence" and "Epidemiology of ADHD." Papers were initially screened by abstract for relevance before undergoing a full-text assessment to ensure satisfaction of the inclusion criteria. Papers were rated based on their methodological quality using a pre-determined criterion. The prevalence of ADHD diagnoses has been increasing significantly over the last three decades. Subgroup analysis showed that the prevalence of diagnosed ADHD was significantly lower in girls, ethnic minorities, and underprivileged children. A similar increase in ADHD symptoms does not accompany the increase in ADHD diagnoses. Instead, increased awareness among underrepresented groups is a key driving factor. When study methods were controlled for, the year of publication had no significant effect on the reported prevalence. There is no significant geographic variation in ADHD prevalence, as variation among studies can be largely attributed to methodological inconsistencies. The study shows the importance of increasing consistency in ADHD diagnostic methods to reduce potential over- and underdiagnosis of ADHD. The study also highlights the need for interventions to reduce barriers faced by underrepresented groups in receiving ADHD diagnoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.